MetaCap

XORTX Therapeutics Statistics

NASDAQ: XRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.839-0.051 (-5.73%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XORTX Therapeutics by the numbers

XORTX Therapeutics has a market capitalization of $1.9 million based on 2.25M shares outstanding. With trailing EPS of $-2.09, XORTX Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.6% below its 50-day average and 58.0% below its 200-day average.

Average daily trading volume is 776.48K shares, or about $651,468 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

XRTX valuation vs. peer median

XRTX compared with the median of 8 peer companies
MetricXRTXPeer medianDifference
Market cap$1.88M$1.92M-2%
Avg. volume776.48K178.77K+334%

Peer median across 8 companies: EOCN, PPCB, PPBT, SBFM, GNPX, DCOY, REVB, ENLV.

Valuation

Price and trading

Previous close
0.89
Open
0.878
Day range
0.8101 – 0.878
52-week range
0.81 – 3.60
Beta
—
Volume
47.88K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
1.88M
Forward Pe
1.05
Eps
-2.09
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.60
Week52 Low
0.81
Avg Volume
776.48K
Shares Outstanding
2.25M
Ma50
1.34
Ma200
2.00
Earnings Date
Nov 12, 2026
Pct From52w High
-76.69%
Pct From52w Low
3.58%

Related